中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Fuzuloparib maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer: a multicenter, randomized, double-blind, placebo-controlled, phase III trial

文献类型:期刊论文

作者Li, Ning1; Zhang, Youzhong2; Wang, Jing3; Zhu, Jianqing4; Wang, Li5; Wu, Xiaohua6; Yao, Desheng7; Wu, Qiang8; Liu, Jihong9; Tang, Junying10
刊名GYNECOLOGIC ONCOLOGY
出版日期2021-08-01
卷号162
ISSN号0090-8258
WOS研究方向Oncology ; Obstetrics & Gynecology
语种英语
WOS记录号WOS:000687070800098
出版者ACADEMIC PRESS INC ELSEVIER SCIENCE
源URL[http://ir.hfcas.ac.cn:8080/handle/334002/125046]  
专题中国科学院合肥物质科学研究院
作者单位1.Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Beijing, Peoples R China
2.Shandong Univ, Qilu Hosp, Jinan, Shandong, Peoples R China
3.Cent South Univ, Xiangya Sch Med, Affiliated Canc Hosp, Changsha, Peoples R China
4.Univ Chinese Acad Sci, Zhejiang Canc Hosp, Canc Hosp, Beijing, Peoples R China
5.Zhengzhou Univ, Henan Canc Hosp, Affiliated Canc Hosp, Zhengzhou, Peoples R China
6.Fudan Univ, Affiliated Canc Hosp, Shanghai, Peoples R China
7.Guangxi Med Univ, Affiliated Tumor Hosp, Nanning, Guangxi, Peoples R China
8.Jiangsu Canc Hosp, Nanjing, Jiangsu, Peoples R China
9.Sun Yat Sen Univ, Canc Ctr, Guangzhou, Peoples R China
10.Chongqing Med Univ, Affiliated Hosp 1, Chongqing, Peoples R China
推荐引用方式
GB/T 7714
Li, Ning,Zhang, Youzhong,Wang, Jing,et al. Fuzuloparib maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer: a multicenter, randomized, double-blind, placebo-controlled, phase III trial[J]. GYNECOLOGIC ONCOLOGY,2021,162.
APA Li, Ning.,Zhang, Youzhong.,Wang, Jing.,Zhu, Jianqing.,Wang, Li.,...&Wu, Lingying.(2021).Fuzuloparib maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer: a multicenter, randomized, double-blind, placebo-controlled, phase III trial.GYNECOLOGIC ONCOLOGY,162.
MLA Li, Ning,et al."Fuzuloparib maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer: a multicenter, randomized, double-blind, placebo-controlled, phase III trial".GYNECOLOGIC ONCOLOGY 162(2021).

入库方式: OAI收割

来源:合肥物质科学研究院

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。